Calcarea carbonica ostrearum C15, 4 g

Clinical and Pharmacological Group: Homeopathic monocomponent drug of animal origin

Pharmacotherapeutic group: Homeopathic remedy

Pharmacological effects

Calcarea carbonica ostrearum is oyster lime, a substance extracted from the underlying shell layer of Casostrea angulata after the white shiny layer called nacre is removed. The substance is a whitish powder with a characteristic odor (ocean smell), practically insoluble in water and in alcohol.

The main component of oyster lime is calcium carbonate, which makes up more than 90% of the total mass. In addition, oyster lime contains:

– magnesium carbonate;
– calcium sulfate;
– silicon dioxide;
– manganese, iron and aluminum salts;
– organic substances such as conchiolin, which consists of numerous amino acids, mainly glycocol, lysine, arginine and tyrosine.

Indications

Key symptoms for prescribing the drug

– disorders of nutrition, growth and bone development;
– polyposis growths;
– tendency to eat inedible things (e.g., chalk, sand);
– intolerance to milk;
– consequences of rickets;
– excessive sweating of the scalp with an acidic smell of sweat;
– lymphoadenopathy.

Main Clinical Applications

Otorhinolaryngology

– acute pathology of the ENT organs in combination with severe cervical maxillary lymphadenopathy in children.

Dermatology

– dermatoses in infants: atopic dermatitis, seborrheic dermitis, erythema glutealis, crusts on the head from which a clear fluid oozes;
– warts (the drug is especially indicated for one bulky plantar wart).

Pulmonology

– asthma.

Developmental abnormalities

– developmental disorders (delayed walking or teething);
– early menarche, heavy menstruation, swollen mammary glands before menstruation.

Gastroenterology

– digestive disorders;
– heartburn, belching sour;
. – In infants, regurgitation with a sour smell;
– milk intolerance;
– a desire to eat eggs.

Parasitology

– enterobiasis.

In adults

Urology

– urolithiasis, polyposis of the bladder.

Metabolism and nutrition

– pathologies associated with overweight and metabolic disorders (obesity, hyperlipidemia, gout, prediabetes).

Neurology

– migraine.

Dermatology

– eczema;
– atopic dermatitis.

Pulmonology

– constitutional treatment of asthma.

Degenerative pathology

– sclerotic hypertension;
– arthritis;
– relapse prevention in polyposis.

Gastroenterology

– cholelithiasis.

Composition

Calcarea carbonica ostrearum

Dilution: C15

Auxiliary substances: sucrose, lactose.

4 g – pellet counter pouches (1) – carton packs.

How to take, the dosage

Sublingually.

The pellets should be taken by mouth 30 minutes before a meal or 60 minutes after a meal.

In children from 0 to 3 years of age the pellets are first diluted by shaking in 10-15 ml of water at room temperature and then given to drink.

The optimal amount per dose is 5 pellets.

Consultation with a physician is necessary to determine the dilution, number and duration of administration.

Interaction

Contraindications

Side effects